Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Expanded agreement between Vertex and HMR receives Hart-Scott-Rodino clearance

Oct. 21, 1999

Dimethaid granted license for Pennsaid Topical Lotion in the U.K.

Oct. 19, 1999

Selective inhibitors of alpha4 integrins designed at Celltech as cell adhesion modulators

Oct. 19, 1999

American Cyanamid claims nonpeptide MMP/TACE inhibitors for wide range of indications

Oct. 18, 1999

Novel caspase-1 inhibitors designed at Vertex

Oct. 15, 1999

Anti-PECAM-1 antisense compounds for inflammation, cell hyperproliferation designed at Isis

Oct. 15, 1999

Celgene discovers new class of compounds inhibiting inflammatory cytokine production

Oct. 14, 1999

Apotex describes new inhibitors of cysteine proteases in recent patent literature

Oct. 8, 1999

New MMP inhibitors from Leo reportedly superior to structurally related compounds

Oct. 8, 1999

PLA2 inhibitors remain a focus of research at Genetics Institute

Oct. 6, 1999

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...